Login or sign up
For business

Cell Receptor

3.9· 10 reviews
Average ratingAverage
3.9/ 5

Based on 10 reviews

530%
430%
340%
20%
10%
Ask AI

Ask Trustburn about Cell Receptor

Based on 10 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About Cell Receptor

Cell Receptor is a small Geneva based startup company, aiming to establish a new option in the treatment of cancer and autoimmune diseases:

The Cell Receptor team has since 2010 been actively engaged in research on cell proliferation and possesses unique knowledge of a very basic control mechanism of cell growth in our body, that was previously unknown and therefore has not been the subject of therapeutic efforts.

Cell Receptor has also knowledge of groups of pharmacological substances able to interfere with this mechanism, and has, basing thereupon, developed a new method for the prevention of cancer metastases.

The treatment has the potential to inhibit cancer metastasis at very reasonable costs. Therefore, it is expected that the clinical demand and thus the expected sales will be quite substantial.

Cell Receptor will fund a clinical trial as a proof of its concept and is expanding its activities for this purpose.